Fluidigm has appointed Douglas Modlin to the position of chief technology officer and vice president of research and development. Before joining the South San Francisco, Calif.-based producer of flexible microfluidics chips, Modlin served as vice president of instrumentation technology research and development at Molecular Devices. He has also worked in various capacities at LJL BioSystems, Affymax, and Affymetrix.
Modlin received his B.S. in electrical engineering from California State Polytechnic University and MS and PhD degrees in electrical engineering from Stanford University.
Prolinx, a Bothell, Wash., protein chip technology company, has made Robert Kaiser chief technology officer. Kaiser replaces Mark Stolowitz, who left the company for personal reasons and who will become vice president of biochip technologies at Lumicyte.
Kaiser has worked at Prolinx since its inception in 1995, holding the positions of director, chemical synthesis, and vice president of research and development. Kaiser received his PhD in chemistry from the California Institute of Technology and performed postdoctoral work in the laboratory of Leroy Hood. Has also held a faculty position at the University of Washington’s molecular biotechnology department.
Karin Hughes, the former director for applications development and manufacturing, will replace Kaiser in his former role as vice president for research and development.
Hughes joined Prolinx in 1996 as a chemist, and has held a number of positions since. She received a PhD in chemistry from the University of Virginia.